Gusheng Tang

1.4k citations
70 papers · 1.0k indexed · h-index 18
Topics
Acute Myeloid Leukemia Research (22 papers)Hematopoietic Stem Cell Transplantation (10 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers)
Journals
SHILAP Revista de lepidopterologíaThe Journal of ImmunologyPLoS ONE
Partner nations
ChinaUnited StatesPoland

In The Last Decade

Gusheng Tang

64 papers receiving 990 citations

Peers

Gusheng Tang
Comparison fields: 5 of 99
  • Molecular Biology 344
  • Immunology 275
  • Oncology 196
  • Clinical Biochemistry 155
  • Hematology 145
Replace Hiroshi Ohkawara with:
Hiroshi Ohkawara Japan
Minoru Tozuka Japan
Simone M. Blattner Germany
Naoya Mimura Japan
Yumi Takiyama Japan
Óscar López‐Franco Spain
Antonella Capozzi Italy
Liangchun Yang China
Yu-Chuen Huang Taiwan
Gusheng Tang relative to Hiroshi Ohkawara Japan Hiroshi Ohkawara's profile →
Citations per field
00.5×2.5×
Hiroshi Ohkawara · 1×
Citations per year

Countries citing papers authored by Gusheng Tang

Since Specialization
Citations

This map shows the geographic impact of Gusheng Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gusheng Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gusheng Tang more than expected).

Fields of papers citing papers by Gusheng Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gusheng Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gusheng Tang. The network helps show where Gusheng Tang may publish in the future.

Co-authorship network of co-authors of Gusheng Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Gusheng Tang. A scholar is included among the top collaborators of Gusheng Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gusheng Tang. Gusheng Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 18
4 6
5 1
6 6
7 14
8 32
9 6
10 17
11 12
12 18
13 1
14 55
15 24
16 25
17 26
18 17
19 0
20 32

About Gusheng Tang

Gusheng Tang is a scholar working on Hematology, Genetics and Oncology, having authored 70 papers that have together received 1.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). The work is most often cited by research in Clinical Biochemistry (155 citations), Immunology (275 citations) and Hematology (145 citations). Gusheng Tang has collaborated with scholars based in China, United States and Poland. Frequent co-authors include Qian Shen, Yanghua Qin, Sheng‐Ming Dai, Jun Zhang, Ding Ren, Zhiwei Wang, Jianmin Yang, Jianmin Wang, Xiaoxia Hu and Hui Cheng. Their work appears in journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026